Current Medical Imaging

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Back Subscribe
Case Report

Posterior Reversible Encephalopathy Syndrome Complicated by Aneurysm Interventional Embolization: A Case Report

Author(s): Yi-Xuan Wang, Yang Liu*, Jian-Feng Xu and Biao Jin

Volume 21, 2025

Published on: 28 April, 2025

Article ID: e15734056384561

Pages: 7

DOI: 10.2174/0115734056384561250418065851

open_access

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Introduction: Complications of Post-Reversible Encephalopathy Syndrome (PRES) following interventional embolization of aneurysms are rarely reported, and PRES disease can be reduced or resolved through prompt and aggressive treatment, resulting in minimal or no residual neurological deficits.

Case Presentation: A 51-year-old female patient with an aneurysm in the pericallosal segment of the left anterior cerebral artery experienced prolonged status epilepticus following aneurysm embolization, attributed to PRES. The diagnosis of PRES was confirmed by symptom improvement and resolution of lesions on imaging studies after one month of treatment involving blood pressure management and prevention of cerebral vasospasm. At the 7- month post-discharge follow-up, the patient's examination indexes were normal without any residual neurological deficits.

Conclusion: This case underscores the importance of promptly identifying and diagnosing PRES, as timely intervention can prevent permanent neurological deficits and mitigate the risk of more severe outcomes.

Keywords: Intracranial aneurysm, Status epilepticus, Posterior reversible encephalopathy syndrome (PRES), Cerebral vasospasm, Aneurysm embolization.

[1]
Zelaya JE, Al-Khoury L. Posterior Reversible Encephalopathy Syndrome. Treasure Island (FL): StatPearls 2024.
[2]
Triplett JD, Kutlubaev MA, Kermode AG, Hardy T. Posterior reversible encephalopathy syndrome (PRES): Diagnosis and management. Pract Neurol 2022; 22(3): practneurol-2021-003194.
[http://dx.doi.org/10.1136/practneurol-2021-003194] [PMID: 35046115]
[3]
Chen S, Hu J, Xu L, Brandon D, Yu J, Zhang J. Posterior reversible encephalopathy syndrome after transplantation: A review. Mol Neurobiol 2016; 53(10): 6897-909.
[http://dx.doi.org/10.1007/s12035-015-9560-0] [PMID: 26666662]
[4]
Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome. J Neurol 2017; 264(8): 1608-16.
[http://dx.doi.org/10.1007/s00415-016-8377-8] [PMID: 28054130]
[5]
Naito H, Yamazaki Y, Takahashi T, Ochi K, Kiura Y, Matsumoto M. A case of posterior reversible encephalopathy syndrome associated with coil embolization of a basilar apex aneurysm. Rinsho Shinkeigaku 2013; 53(7): 518-25.
[http://dx.doi.org/10.5692/clinicalneurol.53.518] [PMID: 23892962]
[6]
Pan-Xing WU, Yun-Fei WANG, Ming ZHONG. Analysis of risk factors for seizures after endovascular treatment in patients with unruptured intracranial aneurysms. Cardiovasc Circul Cir 2022; 41(02): 147-9.
[7]
Grüter BE, Wanderer S, Andereggen L. Incidence and outcome of peri-interventional vasospasm during endovascular or microsurgical treatment of unruptured intracranial aneurysms. Neurosurgery 2023; 92(3): 599-606.
[http://dx.doi.org/10.1227/neu.0000000000002253] [PMID: 36512826]
[8]
Viderman D, Tapinova K, Abdildin YG. Mechanisms of cerebral vasospasm and cerebral ischaemia in subarachnoid haemorrhage. Clin Physiol Funct Imaging 2023; 43(1): 1-9.
[http://dx.doi.org/10.1111/cpf.12787] [PMID: 36082805]
[9]
Romenskaya T, Longhitano Y, Piccolella F, et al. Cerebral vasospasm: Practical review of diagnosis and management. Rev Recent Clin Trials 2023; 18(1): 12-8.
[http://dx.doi.org/10.2174/1574887117666220810121048] [PMID: 35950252]
[10]
Bin ZHANG, Guilian ZHANG, Huqing WANG. Clinical analysis of reversible posterior leukoencephalopathy syndrome of different etiologies. Shanxi Med J 2015; 44(05): 536-8.
[11]
Wu Q, Marescaux C, Wolff V, et al. Tacrolimus-associated posterior reversible encephalopathy syndrome after solid organ transplantation. Eur Neurol 2010; 64(3): 169-77. [PMID: 20699617 DOI: 10.1159/000319032].
[PMID: 20699617]
[12]
Mingda WANG. CT and MRI imaging manifestations and clinical diagnostic value in patients with reversible posterior encephalopathy syndrome. Chin J CT MRI 2024; 22(05): 32-4.
[13]
McKinney AM, Short J, Truwit CL, et al. Posterior reversible encephalopathy syndrome: Incidence of atypical regions of involvement and imaging findings. AJR Am J Roentgenol 2007; 189(4): 904-12.
[http://dx.doi.org/10.2214/AJR.07.2024] [PMID: 17885064]
[14]
Stevens CJ, Heran MK. The many faces of posterior reversible encephalopathy syndrome. Br J Radiol 2012; 85(1020): 1566-75.
[http://dx.doi.org/10.1259/bjr/25273221] [PMID: 23175479]
[15]
Wakisaka K, Morioka T, Shimogawa T. Epileptic ictal hyperperfusion on arterial spin labeling perfusion and diffusion-weighted magnetic resonance images in posterior reversible encephalopathy syndrome. J Stroke Cerebrovasc Dis 2016; 25(1): 228-37.
[http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2015.09.023] [PMID: 26515648]
[16]
Liman TG, Siebert E, Endres M. Posterior reversible encephalopathy syndrome. Curr Opin Neurol 2019; 32(1): 25-35.
[http://dx.doi.org/10.1097/WCO.0000000000000640] [PMID: 30531559]
[17]
Su CHI, Jing LI, Xiangyu PENG. Application effect of levetiracetam combined with midazolam in patients with persistent status epilepticus. China Med Innov 2024; 21(29): 1-5.
[18]
ZHANG O. Analysis of risk factors for post-interventional cerebral vasospasm in patients with intracranial aneurysm. Chin Med J 2023; 58(4): 439-42.
[19]
Du P. Effects of nimodipine and edaravone combination on cerebral vasospasm and delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage. Int J Cerebrovasc Dis 2017; 25(2): 145-9.
[http://dx.doi.org/10.3760/cma.j.issn.1673-4165.2017.02.008]
[20]
Gong FY. Nimodipine combined with edaravone for the treatment of cerebral vasospasm after subarachnoid hemorrhage. Chin J Pract Med 2011; 38(09): 107-8.
[http://dx.doi.org/10.3760/cma.j.issn.1674-4756.2011.09.064]
[21]
Li Y, Jenny D, Castaldo J. Posterior reversible encephalopathy syndrome: Clinicoradiological spectrum and therapeutic strategies. Hosp Pract 1995; 40(1): 202-13.
[http://dx.doi.org/10.3810/hp.2012.02.961]
[22]
Dilibe A, Subramanian L, Poyser TA, et al. Tacrolimus-induced posterior reversible encephalopathy syndrome following liver transplantation. World J Transplant 2024; 14(2): 91146.
[http://dx.doi.org/10.5500/wjt.v14.i2.91146] [PMID: 38947962]